Search research articles
Contact Us
Filters
Showing results (131-140 of 148) with videos related to
Page
of 15
Sort By:
Cancer Immunology Research
|
November 11, 2024
Inflammatory Stress Determines the Need for Chemotherapy in Patients with HER2-Positive Esophagogastric Adenocarcinoma Receiving Targeted Therapy and Immunotherapy
Joseph Tintelnot, Lisa Paschold, Eray Goekkurt, et al.
Cell Reports
|
April 14, 2024
NKp44/HLA-DP-dependent regulation of CD8 effector T cells by NK cells
Benedetta Padoan, Christian Casar, Jenny Krause, et al.
Communications Medicine
|
July 6, 2026
OncoMimic peptide-based immunotherapy EO2401 induces shared T cell clusters in patients with adrenal cancer
Christoph Schultheiß, Brenda Besemer, Edith Willscher, et al.
JAMA Oncology
|
June 23, 2022
Efficacy of Ipilimumab vs FOLFOX in Combination With Nivolumab and Trastuzumab in Patients With Previously Untreated ERBB2-Positive Esophagogastric Adenocarcinoma: The AIO INTEGA Randomized Clinical Trial
Alexander Stein, Lisa Paschold, Joseph Tintelnot, et al.
Journal of Human Immunity
|
April 13, 2026
Dominant-negative PSMB10 disrupts immunoproteasome assembly and leads to transient T lymphopenia
Sujal Ghosh, Yuqin Wang, Christoph Schultheiss, et al.
Journal for Immunotherapy of Cancer
|
July 28, 2021
PD-L1 targeting and subclonal immune escape mediated by PD-L1 mutations in metastatic colorectal cancer
Alexander Stein, Donjete Simnica, Christoph Schultheiß, et al.
Frontiers in Oncology
|
January 6, 2023
Translational analysis and final efficacy of the AVETUX trial - Avelumab, cetuximab and FOLFOX in metastatic colorectal cancer
Joseph Tintelnot, Inka Ristow, Markus Sauer, et al.
Haematologica
|
September 2, 2018
European Myeloma Network recommendations on tools for the diagnosis and monitoring of multiple myeloma: what to use and when
Jo Caers, Laurent Garderet, K Martin Kortüm, et al.
The Oncologist
|
June 27, 2023
Guideline Concordance of Treatment and Outcomes Among Adult Non-Hodgkin Lymphoma Patients in Sub-Saharan Africa: A Multinational, Population-Based Cohort
Nikolaus Christian Simon Mezger, Lucia Hämmerl, Mirko Griesel, et al.
Science Advances
|
August 21, 2024
A20 haploinsufficiency disturbs immune homeostasis and drives the transformation of lymphocytes with permissive antigen receptors
Christoph Schultheiß, Lisa Paschold, Alma Nazlie Mohebiany, et al.
Page
of 15
Search research articles
Search
Showing results (131-140 of 148) with videos related to
Sort By:
Page
of 15
Cancer Immunology Research
|
November 11, 2024
Inflammatory Stress Determines the Need for Chemotherapy in Patients with HER2-Positive Esophagogastric Adenocarcinoma Receiving Targeted Therapy and Immunotherapy
Joseph Tintelnot, Lisa Paschold, Eray Goekkurt, et al.
Cell Reports
|
April 14, 2024
NKp44/HLA-DP-dependent regulation of CD8 effector T cells by NK cells
Benedetta Padoan, Christian Casar, Jenny Krause, et al.
Communications Medicine
|
July 6, 2026
OncoMimic peptide-based immunotherapy EO2401 induces shared T cell clusters in patients with adrenal cancer
Christoph Schultheiß, Brenda Besemer, Edith Willscher, et al.
JAMA Oncology
|
June 23, 2022
Efficacy of Ipilimumab vs FOLFOX in Combination With Nivolumab and Trastuzumab in Patients With Previously Untreated ERBB2-Positive Esophagogastric Adenocarcinoma: The AIO INTEGA Randomized Clinical Trial
Alexander Stein, Lisa Paschold, Joseph Tintelnot, et al.
Journal of Human Immunity
|
April 13, 2026
Dominant-negative PSMB10 disrupts immunoproteasome assembly and leads to transient T lymphopenia
Sujal Ghosh, Yuqin Wang, Christoph Schultheiss, et al.
Journal for Immunotherapy of Cancer
|
July 28, 2021
PD-L1 targeting and subclonal immune escape mediated by PD-L1 mutations in metastatic colorectal cancer
Alexander Stein, Donjete Simnica, Christoph Schultheiß, et al.
Frontiers in Oncology
|
January 6, 2023
Translational analysis and final efficacy of the AVETUX trial - Avelumab, cetuximab and FOLFOX in metastatic colorectal cancer
Joseph Tintelnot, Inka Ristow, Markus Sauer, et al.
Haematologica
|
September 2, 2018
European Myeloma Network recommendations on tools for the diagnosis and monitoring of multiple myeloma: what to use and when
Jo Caers, Laurent Garderet, K Martin Kortüm, et al.
The Oncologist
|
June 27, 2023
Guideline Concordance of Treatment and Outcomes Among Adult Non-Hodgkin Lymphoma Patients in Sub-Saharan Africa: A Multinational, Population-Based Cohort
Nikolaus Christian Simon Mezger, Lucia Hämmerl, Mirko Griesel, et al.
Science Advances
|
August 21, 2024
A20 haploinsufficiency disturbs immune homeostasis and drives the transformation of lymphocytes with permissive antigen receptors
Christoph Schultheiß, Lisa Paschold, Alma Nazlie Mohebiany, et al.
Page
of 15